当前位置: 首页 >> 检索结果
共有 4350 条符合本次的查询结果, 用时 5.7755961 秒

3401. T2-weighted imaging and dynamic contrast‑enhanced imaging in predicting the prognosis in patients with acute-on-chronic liver failure.

作者: Yan Ni Du.;Chun Shuang Guan.;Zhi Bin Lv.;Ming Xue.;Yu Xue Xing.;Ru Ming Xie.
来源: BMC Gastroenterol. 2023年23卷1期285页
Acute-on-chronic liver failure (ACLF) is a syndrome with high 28- and 90-day mortality rates. Magnetic resonance imaging (MRI) has been widely used to diagnose and evaluate liver disease. Our purpose is to determine the value of the imaging features derived from Gd-DTPA-enhanced MRI for predicting the poor outcome of patients with ACLF and develop a clinically practical radiological score.

3402. Novel nomogram to predict the overall survival of postoperative patients with gastric signet.

作者: Donghui Liu.;Ran Ding.;Liru Wang.;Enhong Shi.;Xiaoxue Li.;Chenyao Zhang.;Yan Zhang.;Xuyao Wang.
来源: BMC Gastroenterol. 2023年23卷1期284页
The TNM staging system cannot accurately predict the prognosis of postoperative gastric signet ring cell carcinoma (GSRC) given its unique biological behavior, epidemiological features, and various prognostic factors. Therefore, a reliable postoperative prognostic evaluation system for GSRC is required. This study aimed to establish a nomogram to predict the overall survival (OS) rate of postoperative patients with GSRC and validate it in the real world.

3403. CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer.

作者: Canming Wang.;Yukai Wang.;Jinxia Chen.;Yi Wang.;Chuhong Pang.;Chen Liang.;Li Yuan.;Yubo Ma.
来源: BMC Gastroenterol. 2023年23卷1期283页
The investigational use of zolbetuximab (IMAB362), a groundbreaking monoclonal antibody medication targeting claudin 18.2 (CLDN18.2), for treatment of advanced gastrointestinal cancers is currently underway. The unclear clinicopathological characteristics and tumour immune microenvironment of CLDN18.2-positive gastric cancer (GC) make it difficult to develop and optimize CLDN18.2-targeted therapies.

3404. Transjugular liver biopsy: enlarge the indications for liver biopsy with reliable diagnostic quality.

作者: Miao-Yang Chen.;An-Yin Yang.;Yi-Fan Hu.;Yong-Feng Yang.;Qing-Fang Xiong.;Yan-Dan Zhong.;Du-Xian Liu.
来源: BMC Gastroenterol. 2023年23卷1期282页
Complications and diagnostic efficiency for liver biopsy are main concerns for clinicians. This study aimed to assess the safety and efficacy of transjugular liver biopsy (TJLB) compared with percutaneous liver biopsy (PLB) when patients had equal level of liver function and number of passes, using propensity score matching (PSM).

3405. Selective COX-2 inhibitors do not increase gastrointestinal reactions after colorectal cancer surgery: a systematic review and meta-analysis.

作者: Ting Hu.;Cheng-Jiang Liu.;Xiaoming Yin.;WenJuan Tang.;LanFang Yin.;Hui Bai.;FangFang Liu.;Dan Wang.;YiLei Li.
来源: BMC Gastroenterol. 2023年23卷1期281页
The effectiveness of selective COX-2 inhibitors in preventing colorectal cancer recurrence has been demonstrated, however it is unknown how safe and successful they will be over the long term. As a result, we looked at the efficacy, safety, and consequences of adding COX-2 inhibitors to the treatment plan afterward.

3406. A Mysterious Abdominal Pain.

作者: Qingmin Zeng.;Dongbo Wu.;Hong Tang.
来源: Gastroenterology. 2024年166卷1期27-30页

3407. A novel long non-coding RNA XLOC_004787, is associated with migration and promotes cancer cell proliferation by downregulating mir-203a-3p in gastric cancer.

作者: Renjie Miao.;Zhendong Yao.;Bingheng Hu.;Tao Jin.;Donglai Zhu.;Yun Shi.;Yuhua Gong.;Shihe Shao.;Chen Shao.
来源: BMC Gastroenterol. 2023年23卷1期280页
Long noncoding RNAs (lncRNAs) have been identified as important regulatory factors implicated in a wide array of diseases, including various forms of cancer. However, the roles of most lncRNAs in the progression of gastric cancer (GC) remain largely unexplored. This study investigates the biological function and underlying mechanism of a novel lncRNA, XLOC_004787 in GC.

3408. An Unusual Case of Gastric Polyposis.

作者: Masaya Iwamuro.;Seiji Kawano.;Motoyuki Otsuka.
来源: Gastroenterology. 2023年165卷5期1110-1113页

3409. Magnetic-controlled capsule endoscopy performance in aging patients.

作者: Jiaxin Li.;Li Li.;Yueyuan Li.;Long Chen.;Rongyue Liang.;Meilin Liu.;Hongmei Jiao.
来源: BMC Gastroenterol. 2023年23卷1期277页
The increasing elderly population and wide use of magnetic capsule endoscopy (MCE) have led to more attention to elderly patients.

3410. Protective role of thymoquinone in hyperlipidemia-induced liver injury in LDL-R-/-mice.

作者: Fei Wang.;Wei Yao.;Dexin Yu.;Yuhua Hao.;Yuling Wu.;Xiaoqing Zhang.
来源: BMC Gastroenterol. 2023年23卷1期276页
Hyperlipidemia, a heterogeneous group of disorders characterized by elevated plasma lipids in the blood, causes severe health problems, leading to fatty liver disease and nonalcoholic fatty liver disease. Thymoquinone, the major active chemical component of Nigella sativa, reportedly exerts a vast array of biological effects. Various studies have reported that Thymoquinone protects against liver injury.

3411. Bioinformatics analysis of hedgehog interacting protein in colorectal cancer: a study based on GEO data and TCGA data.

作者: Fengyihuan Fu.;Yuan Zhang.;Jubin Feng.;Yuqiang Nie.
来源: BMC Gastroenterol. 2023年23卷1期278页
Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide. Hedgehog Interacting Protein (HHIP) is evolutionarily conserved protein, which are important morphogens for a wide range of developmental processes,However, the specific role and mechanism of HHIP in CRC remains not fully understood. In this study, we first performed pan-cancer analysis for HHIP's expression via The Cancer Genome Atlas (TCGA) and The Genotype-Tissue Expression (GTEx) data and found that HHIP might be a potential anti-oncogene for CRC. Subsequently, non-coding RNAs (ncRNAs) contributing to down-regulated HHIP expression were identified through a combination of a series of in silico analyses, including expression and correlation analysis. Finally, the LINC02381/miR-577 complex was identified as the top potential upstream regulator of HHIP in CRC. In addition, HHIP expression level was significantly correlated with tumor immune cell infiltration, biomarkers of immune cells, and immune checkpoint expression. Overall, our findings clarified ncRNAs-mediated down-regulation of HHIP which was associated with poor prognosis and tumor immune infiltration in CRC.

3412. Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway.

作者: Hui Cheng.;Qinfang Li.
来源: BMC Gastroenterol. 2023年23卷1期279页
Cholangiocarcinoma (CCA) is a refractory malignancy derived from bile duct epithelial cells. This study aimed to explore the role and molecular mechanisms of action of sevoflurane in CCA.

3413. Differential expression of PLAC1 and Netrin-1 in liver metastasis of colorectal cancer and its predictive value.

作者: Zhijun Wang.;Lei Deng.;Xiwen Xu.;Lianwu Zhao.
来源: BMC Gastroenterol. 2023年23卷1期275页
To explore the differential expression of placental specific gene 1 (PLAC1) and neurite guidance factor 1 (netrin-1) in colorectal cancer (CRC) liver metastasis and its predictive value.

3414. A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy.

作者: Jingjing Li.;Jiadi Du.;Yuying Li.;Mingzhu Meng.;Junjie Hang.;Haifeng Shi.
来源: BMC Gastroenterol. 2023年23卷1期274页
This study aimed to evaluate the predictive value of computed tomography (CT) texture features in the treatment response of patients with advanced pancreatic cancer (APC) receiving palliative chemotherapy.

3415. Comprehensive analysis of CXCL14 uncovers its role during liver metastasis in colon cancer.

作者: Lei Zhou.;Yan Zhang.;Ming Wei.;Kangming Du.;Jing Lin.;Lihong Wei.
来源: BMC Gastroenterol. 2023年23卷1期273页
The most common cause of death for colon cancer patients is liver metastasis.

3416. Deep Learning-Enabled Diagnosis of Liver Adenocarcinoma.

作者: Thomas Albrecht.;Annik Rossberg.;Jana Dorothea Albrecht.;Jan Peter Nicolay.;Beate Katharina Straub.;Tiemo Sven Gerber.;Michael Albrecht.;Fritz Brinkmann.;Alphonse Charbel.;Constantin Schwab.;Johannes Schreck.;Alexander Brobeil.;Christa Flechtenmacher.;Moritz von Winterfeld.;Bruno Christian Köhler.;Christoph Springfeld.;Arianeb Mehrabi.;Stephan Singer.;Monika Nadja Vogel.;Olaf Neumann.;Albrecht Stenzinger.;Peter Schirmacher.;Cleo-Aron Weis.;Stephanie Roessler.;Jakob Nikolas Kather.;Benjamin Goeppert.
来源: Gastroenterology. 2023年165卷5期1262-1275页
Diagnosis of adenocarcinoma in the liver is a frequent scenario in routine pathology and has a critical impact on clinical decision making. However, rendering a correct diagnosis can be challenging, and often requires the integration of clinical, radiologic, and immunohistochemical information. We present a deep learning model (HEPNET) to distinguish intrahepatic cholangiocarcinoma from colorectal liver metastasis, as the most frequent primary and secondary forms of liver adenocarcinoma, with clinical grade accuracy using H&E-stained whole-slide images.

3417. Validation of a new simple scoring system to predict spontaneous bacterial peritonitis in patients with cirrhosis and ascites.

作者: Ngoc Cao Huynh.;Thong Duy Vo.
来源: BMC Gastroenterol. 2023年23卷1期272页
Recently, a simple scoring system named the Mansoura scoring system was developed to predict spontaneous bacterial peritonitis (SBP) in patients with cirrhosis and ascites. However, the efficacy of this newly developed system has not been extensively investigated. We aimed to validate a new simple scoring system for the rapid diagnosis or exclusion of SBP without paracentesis.

3418. Comment Regarding "Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial".

作者: Neal S LeLeiko.
来源: Gastroenterology. 2023年165卷5期1307-1308页

3419. Role of the 3'-UTR in BMPR2 as a Novel Predisposition Gene for Hereditary Colorectal Polyposis.

作者: Maikel P Peppelenbosch.;Liudmila L Kodach.
来源: Gastroenterology. 2023年165卷6期1577页

3420. Challenges to the Fecal Occult Blood Test: Where Is the Way Forward?

作者: Chenglong Wang.;Shengbing Zhao.;Yu Bai.
来源: Gastroenterology. 2023年165卷6期1578-1579页
共有 4350 条符合本次的查询结果, 用时 5.7755961 秒